• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pierre Fabre and Lonza Enter Manufacturing Agreement

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Qosina Strengthens Aseptic Capabilities

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Pierre Fabre and Lonza Enter Manufacturing Agreement

    Qosina Strengthens Aseptic Capabilities

    MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies

    Antheia Receives $40 million in Venture Debt Financing

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine

    Cullinan Oncology, Taiho to Develop & Commercialize CLN-081/TAS6417 in the U.S.

    BioNTech Breaks Ground on First mRNA Vax Mfg. Facility in Africa

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    IDT Biologika

    Kyongbo Pharmaceutical

    Aphena Pharma Solutions

    Vector Partners Limited
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    IDT Biologika

    Kyongbo Pharmaceutical

    Aphena Pharma Solutions

    Vector Partners Limited
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Cobra Biologics Joins COVID-19 Consortium

    Aims to rapidly develop, scale-up and produce potential adenoviral vaccine candidate for COVID-19.

    Related CONTENT
    • FDA Clears IND Application for Vaxart Oral COVID-19 Vaccine
    • Valneva Partners with UK Government for COVID-19 Vaccine
    • iBio Advances COVID-19 Vaccine Candidate
    • Expediting a COVID-19 Vaccine: FDA Approval Process
    • COVID-19: Racing for a Vaccine
    03.31.20
    Cobra Biologics, an international CDMO, is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19 (ChAdOx1), for fast-tracked clinical trials for COVID-19. ChAdOx1, is one of five frontrunner vaccines in development around the world, and expected to be the UK’s first COVID-19 vaccine. The ChAdOx1 consortium includes the University of Oxford Jenner Institute, University of Oxford Clinical Biomanufacturing Facility, the Vaccines Manufacturing and Innovation Centre (VMIC), Advent Srl, Pall Life Sciences, Cobra Biologics and Halix BV.
     
    The ChAdOx1 consortium is currently recruiting in the UK to test the vaccine’s efficacy. Cobra is actively planning for a fast set-up phase to facilitate the production of a GMP working cell bank and then 200L GMP viral vaccine. The consortium partners expect to develop and manufacture the vaccine candidate in multiple batches, to support a 1 million dose scale batch size by summer 2020.
     
    Developed at the Jenner Institute, ChAdOx1 is a promising vaccine technology for COVID-19 as it can generate a strong immune response from one dose. The vaccine candidate allows it to be given safely to vulnerable members of the public, including children, the elderly and those with a pre-existing condition, such as diabetes.
     
    Peter Coleman, Chief Executive at Cobra Biologics, said: “The organizations within the consortium led by the Jenner Institute are experts from across industry and academia, with the experience, capability and conviction to deliver a successful outcome. Cobra is privileged to have been invited to participate and contribute to the fight against COVID-19, as this virus continues to impact the globe exponentially.”
    Related Searches
    • Manufacturing
    • contractpharma
    • CDMO
    • facility
    Suggested For You
    FDA Clears IND Application for Vaxart Oral COVID-19 Vaccine FDA Clears IND Application for Vaxart Oral COVID-19 Vaccine
    Valneva Partners with UK Government for COVID-19 Vaccine Valneva Partners with UK Government for COVID-19 Vaccine
    iBio Advances COVID-19 Vaccine Candidate iBio Advances COVID-19 Vaccine Candidate
    Expediting a COVID-19 Vaccine: FDA Approval Process Expediting a COVID-19 Vaccine: FDA Approval Process
    COVID-19: Racing for a Vaccine COVID-19: Racing for a Vaccine
    Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine
    Intravacc, Therapyx Develop First Prophylactic Gonorrhea Vaccine Intravacc, Therapyx Develop First Prophylactic Gonorrhea Vaccine
    Expediting a COVID-19 Vaccine: FDA Approval Process Expediting a COVID-19 Vaccine: FDA Approval Process
    Catalent and AstraZeneca Enter Vaccine Manufacturing Deal Catalent and AstraZeneca Enter Vaccine Manufacturing Deal
    Is Blockchain Key to COVID-19 Vaccine Distribution? Is Blockchain Key to COVID-19 Vaccine Distribution?
    IDT Biologika Fills SARS-CoV-2 Vaccine Candidate IDT Biologika Fills SARS-CoV-2 Vaccine Candidate
    GSK Buys 10% Stake in German Vaccine Developer CureVac GSK Buys 10% Stake in German Vaccine Developer CureVac
    A Guide to Vaccine Development from Lubrizol Life Science A Guide to Vaccine Development from Lubrizol Life Science
    Pioneering Medicine Forward Pioneering Medicine Forward
    Duke, GenScript, A*STAR Enter COVID-19 Pact Duke, GenScript, A*STAR Enter COVID-19 Pact

    Related Content

    • Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News

      FDA Clears IND Application for Vaxart Oral COVID-19 Vaccine

      Recruitment for the Phase 1 clinical study is expected to start this month.
      Contract Pharma Staff 09.16.20

    • Valneva Partners with UK Government for COVID-19 Vaccine

      Valneva Partners with UK Government for COVID-19 Vaccine

      UK secures supply of 60 million doses with options over another 130 million doses between 2022 and 2025.
      Contract Pharma Staff 09.16.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
      iBio Advances COVID-19 Vaccine Candidate

      iBio Advances COVID-19 Vaccine Candidate

      IBIO-201 induced the production of anti-spike neutralizing antibodies in tests.
      Contract Pharma Staff 09.10.20


    • Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
      Expediting a COVID-19 Vaccine: FDA Approval Process

      Expediting a COVID-19 Vaccine: FDA Approval Process

      The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.
      Kristin Brooks, Managing Editor 09.09.20

    • COVID-19: Racing for a Vaccine

      COVID-19: Racing for a Vaccine

      Amélie Boulais of Sartorius discusses the landscape and challenges for developing a vaccine against the SARS-Cov-2 virus
      Kristin Brooks, Contract Pharma 09.09.20

      Trending
      • Machine Learning-based Predictive Modeling: Notable Uses In Clinical Trials
      • 17th Annual Contracting & Outsourcing Conference Photos
      • Pierre Fabre And Lonza Enter Manufacturing Agreement
      • MilliporeSigma Opens $65M CDMO Facility For Cancer Therapies
      • New Agreement Paves Way For Development Of First African-owned COVID-19 Vaccine
      Breaking News
      • Qosina Strengthens Aseptic Capabilities
      • Pierre Fabre and Lonza Enter Manufacturing Agreement
      • Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
      • MasterControl and Elemental Machines Form Biomanufacturing Partnership
      • MilliporeSigma Opens $65M CDMO Facility for Cancer Therapies
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Florida Food Products Acquires Javo
      Roquette Launches Nutralys Rice Protein
      New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
      Coatings World

      Latest Breaking News From Coatings World

      The Southern Society for Coatings Technology's 84th Annual Technical Conference A Success
      PPG to Showcase Specialty Automotive, Aerospace Adhesives, Sealants at Adhesives & Bonding Expo
      PPG’s New Paint for a New Start Initiative to Transform 25-plus Schools Worldwide
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Magnetic Insight Announces $17 Million in Series B Funding
      BreatheSuite Adds Brad Fluegel to its Board
      Labcorp Launches At-Home Collection Device for Diabetes Risk Testing
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Pierre Fabre and Lonza Enter Manufacturing Agreement
      MasterControl and Elemental Machines Form Biomanufacturing Partnership
      Qosina Strengthens Aseptic Capabilities
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Benefit Exec Joins Madison Reed's Board
      Peroni & Ellis Brooklyn Launch Fragrance Collection Inspired by Italian Spritz Cocktails
      Rhode Is Trending for June, Trendalytics Says
      Happi

      Latest Breaking News From Happi

      Caire Beauty to Celebrate Menopause Empowerment Day
      Beautycounter Launches Text Campaign for FDA Safety and Landmark Advancements Act
      Mary Kay Inc. Presents Skin Health Findings at Society for Investigative Dermatology Conference
      Ink World

      Latest Breaking News From Ink World

      British Coatings Federation Posts Online History
      Orion Announces Price Increases, Reduced Payment Terms
      INX Troubleshooting Guide App Adds New Solutions
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      PCMC teams with IGT, Fujifilm makes big announcement and more
      Loftware recognized as 'AIDC Company of the Year'
      Schreiner MediPharm highlights sustainability of Needle-Trap technology
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Tranzonic Names VP of Supply Chain
      Ontex Climate Action Targets Approved by Science-Based Targets Initiative
      Suominen Test Center Assesses Biodegradability of Nonwovens
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      3Spine Inc. Receives IDE Approval for U.S. Pivotal Clinical Trial
      Volume-Based Procurement to Reduce Chinese Orthopedic Market Value
      Isto Biologics Rolls Out Influx Fibrant
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      NREL Names Jennifer Logan to Leadership Team as CFO
      National Grid Renewables Orders 2 GW of First Solar Modules
      EO System Company Ltd. Picks eMagin’s OLED Microdisplays for Global Projects

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login